Skip to main content

Recombinant Human IL-2 (CD122-Directed) Protein, CF

R&D Systems, part of Bio-Techne | Catalog # BT-002DBR

AI Modified Protein
R&D Systems, part of Bio-Techne
(2)
Catalog #
Availability
Size / Price
Qty
Loading...
BT-002DBR-100
BT-002DBR-010
BT-002DBR-01M
BT-002DBR-500
BT-002DBR-050

Key Product Details

Il-2 receptor engagement can impact the growth and phenotype of cultured immune cells such as T, NK, or Tumor Infiltrating T cells. By engaging the beta receptor (CD122) with higher affinity, continued proliferation of T cells has been observed. Utilizing generative AI to develop an optimized IL-2 cytokine with enhanced beta receptor (CD122) engagement offers superior performance while maintaining greater than 95% homology to its wild-type counterpart including:
  • Enhanced CD122 Binding: Increased affinity to the IL-2 beta receptor (CD122) with decreased affinity to IL-2 alpha receptor (CD25), allowing proliferation of effector T cells
  •  allowing proliferation of effector T cells
  • Improved Output: Maintains growth of CD8+/CD4+ T cells for workflows aimed at extending proliferation of T cells.
  • Sustained Phenotype: Improved proliferation capacity without increased exhaustion nor more terminally differentiated T cells.
Source: E. coli
Accession #: P60568.1
Applications: Bioactivity